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The concerted application of element specific atomic spectral detection for chromatographic eluent monitoring
allows previously unexploited qualitative and quantitative analytical concepts to be developed for the
determination of selenium species. Selenium speciation is vital in order to better understand its metabolism and
biological significance in clinical chemistry, biology, toxicology, and nutrition. Fluoroacid ion pair HPLC with
ICP-MS detection and GC derivatization with atomic emission detection (AED) together aid analysis and
elucidation of reaction pathways of selenium compounds in high selenium enriched yeast, as used widely in
nutritional and clinical cancer preventative studies. Comparisons between currently produced and archived
selenized yeasts show major differences in speciation. The formation of selenomethionine selenoxide and the
identification of Se–S bonded S-(selenomethyl)-cysteine in archived nutritional yeast may be important for
short and long term stability and nutritional activity studies.
Introduction
Selenium has a vital nutritional role and has cancer chemopre-
ventive properties, but the speciation of selenium compounds,
which is needed to define their biological roles, presents a great
challenge.1 The study of selenium toxicity above the limited range
of nutritional necessity also mandates high accuracy and
precision in selenium speciation. Ionic selenium and organose-
lenium compounds, selenoamino acids and related compounds,
are present in a diverse range in both enriched and natural
matrixes. The human nutritional metabolic need for selenium
derives from its incorporation into the active selenol group
(–SeH) centers of glutathione peroxidase, thioredoxin reductase
and other selenoenzymes.2,3 Cancer chemoprevention is asso-
ciated with inorganic selenium salts, selenoamino acids and
organoselenium compounds such asmethaneselenol CH3SeH.
4–6
Selenoproteins contain selenium in the form of selenocysteinyl
residues; proteins that contain this element in the form of
selenomethionyl residues are not formally classified as seleno-
proteins. Analytical techniques for the determination of selenium
species have been reviewed,7–10 but many methods have only
been applied to a few commercially available standards. Table 1
shows some selenium species that have attracted nutritional,
clinical and bioanalytical attention.
Treatment of selenium-containing samples with proteolytic
enzymes, followed by extraction, enables more than 90% of
total selenium to be recovered and speciated, perfluoro acid ion
pair reversed phase HPLC giving good separation of selenite,
selenate, methaneseleninic acid, selenoamino acids, selenox-
ides, etc. HPLC interfaced with the inductively coupled plasma
mass spectrometer (ICP-MS) gives total element determination
and selenium specific detection to low ppb levels and has been
applied to a number of natural and enhanced level selenium
speciation studies.4,11–17 Volatile compounds such as dialkyl
selenides and selenoamino acid derivatives have been deter-
mined by headspace–capillary gas chromatography with
atomic emission element specific detection (GC-AED).17,18
Selenium-enriched yeast supplements have given statistically
significant reductions in cancer incidence and mortality in
human intervention trials19 and it has been shown that high-
selenium garlic is effective in rat mammary cancer chemopre-
vention.20 It has been proposed that anti-tumorigenic activity
arises from selenomethionine (SeMet) and selenocysteine
(SeCys), and methylated forms such as Se-methyl-SeCys that
are converted to metabolites, including methaneselenol
(CH3SeH).
5,21 ‘High Selenium Yeast’ was developed to meet
the need for a reliable, biologically available source of
selenium. Under agreements with the Division of Cancer
Table 1 Inorganic and organoselenium analytical target compounds
1 Selenous acid, selenite SeO3
22 2 Selenic acid, selenate SeO4
22
3 Selenocyanate SeCN2 4 Methaneseleninic acid anion MeSe(O)O2
5 Methaneselenenic acid anion MeSeO2 6 Dimethyl selenide Me2Se
7 Dimethyl diselenide Me2Se2 8 Methaneselenol MeSeH
9 Trimethylselenonium cation Me3Se
1
10 Selenocysteine H3N
1–CH(COO2)–CH2–SeH
11 Selenocystine H3N
1–CH(COO2)–CH2–Se–Se–CH2–CH(COO
2)–NH3
1
12 Selenomethionine H3N
1–CH(COO2)–CH2–CH2–Se–Me
13 Selenomethionine oxide hydrate H3N
1–CH(COO2)–CH2–CH2–Se(OH)2–Me
14 Se-Methylselenocysteine H3N
1–CH(COO2)–CH2–Se–Me
15 c-Glutamyl-methylselenocysteine H3N
1–CH2–CH2–CO–NH–CH(COO
2)–CH2–Se–Me
16 Selenocystathionine H3N
1–CH(COO2)–CH2–CH2–Se–CH2–CH(COO
2)–NH3
1
17 Selenohomocysteine H3N
1–CH(COO2)–CH2–CH2–SeH
18 Se-Adenosylselenohomocysteine NH2–CH(COOH)CH2CH2SeCH2C4H5O3C5N4NH2
Prevention, National Cancer Institute (DCP-NCI), clinical
trials have been initiated to test hypotheses that Se-supple-
mentation improves health by reducing risks of cancers of the
colon, lung and prostate. The Clark study19 is now being
extended in the ‘SELECT’-Selenium and Vitamin E Cancer
Prevention Trial, which will monitor the incidence of prostate
cancer in 32 400 healthy men over a 12-year study period, in
which selenomethionine will be employed as the selenium
dosage agent.22 The DCP-NCI has noted that, should these
studies confirm the previously reported cancer-protective
effects of Se, then two further steps will be required in order
to ascribe clinical benefit to the dietary supplement. The Se-
compounds in the supplement must be identified and evidence
of batch-to-batch reproducibility with respect to those Se-
compounds must be available. Analyses of commercially
available preparations have shown organically-bound Se to
vary in range from 0 to 97% of total Se content, with some
products showing only a few Se-species and others containing
more than 20 different Se-compounds.11,16,23,24
A typical commercially available selenized yeast such as
SelenoExcell2 (Cypress) has a Se content of 1250 mg g21 dry
matter (¡5%), a minimum protein content of 50% (w/w), and a
phosphate content in the range of 2.5–3.4% (w/w). However,
because it is a biological product, batch-to-batch variation in
its composition is possible, requiring informative and rigorous
QA/QC protocols. The greater part of the Se in SelenoExcell2
is organically bound, and the major single component (released
from the protein-bound form by enzymatic digestion and
extraction) is selenomethionine (SeMet), comprising 60–70% of
the total Se.11 However, it is possible that selenized yeast may
contain organoselenium species or precursors that may be more
anti-carcinogenically potent than SeMet.
We now report a more extensive characterization study of a
number of yeast samples, including elucidation of changes in Se
speciation upon lengthy storage and, in particular, speciation
of material used in the human intervention trial of Clark et al.19
The complementary techniques of HPLC-ICP-MS and GC-
AED were used to characterize the materials.
Experimental
Instrumentation
An Elan 5000 inductively coupled plasma mass spectrometer
(PerkinElmer Sciex, Norwalk, CT, USA) was used for total
selenium determination and HPLC-ICP-MS. Samples were
introduced using a cross-flow nebulizer and double-pass spray
chamber. For total selenium determination 82Se and 77Se were
monitored with 74Ge as an internal standard using a 250 ms
dwell time (n ~ 27); isobaric interference from 74Se was
automatically corrected as confirmed for certified materials.16
The chromatographic system consisted of a liquid chromato-
graphic pump (SP8810, Spectra-Physics, San Jose, CA, USA),
and either a 5 mm Symmetry Shield RP8 bonded hybrid
stationary phase column (3.9 mm6 15 cm) or a 5 mm XTerra
RP-C18 column ((4.6 mm 6 15 cm) Waters Corporation,
Milford, MA, USA), that has a polar modifier group between
the C8 group and the silica base. The column was connected to
the nebulizer with PEEK tubing (30 cm 6 0.25 mm id). The
mobile phase compositions were as follows: 991 1 (v/v) water–
methanol was used in each case with (a) 0.1% trifluoroacetic
acid (TFA) or (b) 0.1% heptafluorobutanoic acid (HFBA).
A Hewlett-Packard HP 5921A atomic emission detector
(AED) interfaced with a HP 5890II gas chromatograph was
used. The injection port (splitless) was maintained at 250 uC:
the GC oven was programmed from 100 uC (initial temperature
for 5 min) to 200 uC at 5 uCmin21, holding at 200 uC for 5 min.
A HP 1 25 m 6 0.32 mm 6 0.17 mm (film thickness) column
was used. The helium plasma gas flow was kept at 180 ml
min21. Hydrogen was used as reagent gas, with detection at
181 nm (S) and 196 nm (Se).
A HP mass selective detector (Hewlett-Packard Co.)
interfaced with a HP 6890 GC was used for GC-MS analysis,
using a HP-5 (5% phenyl, 95% polydimethylsiloxane, 30 m 6
0.25 mm 6 0.25 mm) column. The oven was run at an
isothermal temperature of 160 uC and helium was used as a
carrier gas at a flow rate of 2 ml min21. The split ratio was 10 : 1
and the column head pressure was 13.28 psi.
Chemicals
Sodium selenate, sodium selenite, DL-selenomethionine, DL-
selenoethionine, DL-selenocystine, Protease XIV, and ethyl
chloroformate (ECF) were obtained from Sigma Chemical
Company (St. Louis, MO, USA). Se-Methyl-DL-selenocysteine
was obtained from Dr. Howard Ganther (University of
Wisconsin, Madison, WI, USA). Plasma selenium and
germanium standard solutions (1000 mg ml21) were obtained
from Spex Industries Inc., Edison, NJ, USA. Selenium-
enriched yeast (SelenoExcell2, also designated SelenoPrecise)
was obtained from Cypress Inc., Fresno, CA, USA. Archived
selenized yeast and tablets fabricated from it, as employed in
the human intervention trials,19 were obtained from the
University of Arizona, McKesson Corp. and Cornell Uni-
versity (archive numbered as N1–N13). Stock solutions of
selenoamino acids were prepared in 0.2 M HCl. A stock
solution of sodium selenate was prepared in 2% (v/v) HNO3,
while the plasma selenium standard was used as a stock
solution of sodium selenite. Working solutions were diluted
with mobile phase and stored in the dark between 0–4 uC. The
standards used in measurements were thus 0.02–0.002 M in
HCl or 0.0002% in HNO3 after dilution, these acid concentra-
tions having no effect on chromatographic separation and
speciation considering the 10 mL volumes injected.
Procedure
Sample preparation for HPLC. The enzymatic digestion/
extractions followed the procedures reported earlier and are
only briefly summarized.11 Five ml of distilled deionized water
was added to 0.2 g of powdered sample together with 0.02 g of
‘Protease XIV’ enzyme in a 15 mL centrifuge tube, then the
mixture was shaken for 24 h at room temperature. After the
digestion and extraction, the samples were centrifuged at 3000g
for 20 min and filtered successively through a 0.45 mm
polypropylene filter and an ‘Ultrafree’ centrifugal filter
(Millipore Corp., Bedford, MA) having a 10 000 Dalton
molecular weight cut-off. Samples were acidified before
injection (900 ml of extract plus 100 ml of concentrated
HFBA, i.e. 10% HFBA in extract).
Derivatization of standard selenoamino acids for GC-AED
and GC-MS. Selenoamino acid standards were derivatized
with ethylchloroformate (ECF) using the method developed by
Husek.25 Stock solutions of the amino acids were prepared by
weighing 10 mg of the standard and dissolving in 1 ml of 0.1 M
HCl to make 10 000 ppm standard solutions. Then, 1000 ppm
derivatized standard solutions were prepared as follows: 100 ml
of the 10 000 ppm selenoamino acid stock solution was treated
with 1 ml of water–ethanol–pyridine mixture (60 : 32 : 8), 50 ml
of ECF was added and the mixture shaken until gas evolution
ceased. Then, 1 ml of chloroform (containing 1% ECF) was
added and the derivatives were extracted into the organic phase
which was evaporated to dryness. The residue was redissolved
in 1 ml of hexane and 1 ml was injected into the GC-AED or
GC-MS.
A 2-ml portion of the aqueous (non-acidified) extract
prepared for HPLC analysis was also taken for examination
by GC-AED. A water–ethanol–pyridine mixture (60 : 32 : 8 by
volume—15 ml) was added followed by ethyl chloroformate
(ECF—1 ml), the sample was shaken and any evolved gas
vented. Ethylated derivatives were extracted into 3 ml of
chloroform (containing 1% ECF) by shaking for 30 min. The
chloroform layer was separated, solvent was removed with a
flow of nitrogen and the residue was redissolved in 100 ml
chloroform or hexane. One ml was injected.
Liquid chromatographic methods. The separation, qualita-
tive identification and quantitative determination of the wide
range of inorganic selenium and organoselenium present or
potentially present in the complex samples requires the
application of a complementary range of state-of-the art
techniques.
High-performance liquid chromatography provides the core
methodology, since some of the target chemical species are not
directly amenable to gas phase separations. However, the need
is to develop and apply a complementary suite of separation
methods which, when applied together, will give the greatest
confidence of reliable information.
While ion exchange chromatography has been extensively
applied, we have found reversed phase ion pair HPLC to be
successful. Incorporation of a fluorinated acid ion-pairing
agent to establish a pH of ca. 2–2.5 enables anions such as
selenite, selenate, etc., to be protonated completely to give
neutral species that are eluted rapidly. Cationic (positive)
species, such as trimethylselenonium, are paired with the
fluorinated acid anion to give ‘neutral’ ion pairs and are
retained somewhat more. Selenoamino acids are protonated
and also ‘ion paired’ with the fluoroacid anions and elute at
different times depending upon their degree of retention on the
stationary phase. Different fluorinated acids provide different
degrees of separation in different regions of the chromatogram.
Larger molecules, such as peptides and proteins, are not eluted
and separated by this procedure, although intermediate species
such as Se-adenosyl-selenohomocysteine and c-glutamyl-Se-
methylselenocysteine can be eluted in a reasonable time frame.
Results and discussion
Selenium specific HPLC-ICP-MS chromatograms of enzymatic
(Protease XIV) hydrolyzate products from a 1250 ppm
reference yeast (SelenoExcell2), obtained on the Symmetry
Shield2 column, are shown in Fig. 1. The response scale of the
lower chromatogram is expanded approximately 25-fold. In
this case selenomethionine is clearly the major selenium species
eluted. In terms of percentage selenium distributions, as
expressed as total selenium area response of eluted peaks (a
valid approach since selenium response is independent of
molecular structures), selenomethionine comprised 84% of
eluted selenium. The only other positively identified selenium
compounds were selenite (0.1%), c-glutamyl-Se-methyl-seleno-
cysteine (0.5%) and Se-adenosylselenohomocysteine (0.5%), as
authenticated by retention of standards and HPLC-MS. We
have reported a similar separation for a more highly enriched
yeast (1922 ppm Se—Nutrition 21, San Diego, CA).11 For the
latter yeast there were indications of other selenium com-
pounds including Se-cystathionine, Se-lanthionine and Se-
methylselenocysteine at levels too low for mass spectral
confirmation. In these chromatograms an ‘unknown’ selenium
peak that does not correspond to any known standards but
comprises ca. 5% of eluted selenium, elutes at ca. 2.5 min on the
Symmetry Shield2 column (U1). Another small unidentified
peak (ca. 2%-eluted selenium) appears at ca.10.5 min (U2). U1
proves to be related to the oxidation of selenomethionine, as is
shown subsequently. We show U2 to be a previously
unidentified organoselenium species.
Replicate determinations made for multiple samples of
SelenoExcell2 (n ~ 3 for each of 3 batches) produced
chromatograms (as in Fig. 1) which could be overlaid and
showed RSD values for the quantitation of identified
components of 1% or better. Provided that the Protease XIV
enzyme employed for digestion was kept at240 uC when not in
use, virtually no changes in chromatographic profiles were seen
in six months. This ‘reference’ yeast reproducably showed ca.
13–14% of total chromatographable selenium eluted before
selenomethionine and less than 1% eluted after that peak. Each
time a new group of experiments were run or a new sample of
Protease XIV was used the ‘reference’ yeast was determined to
confirm consistent analytical behavior.
Table 2 shows the percentage compositions of the four
previously identified selenium species obtained for a number of
selenized yeasts with different total selenium contents. Total
eluted selenium referenced against element content range from
69.2–94%, repeatability values being as noted above. Of this
elutable selenium, the selenomethionine percentage ranged
from 62.5% to 89.1%, selenite was always very low, but the
Se-adenosylselenohomocysteine content varied more widely
(0.5–7.4%). Unknown peaks U1 and, to a lesser extent, U2 were
also present in the low percent range.
Selenium-enriched nutritional tablets19
Previously reported selenium speciation and quantitation
showed markedly different results for selenium-enriched tablets
obtained from various sources. Sutton et al. in particular23
noted a wide variation among supplement tablets. A typical
supplement tablet weighs ca. 500 mg and contains 200 mg of
selenium present in 160 mg of selenized yeast. The remaining
excipients comprise a range of ingredients such as calcium
phosphate, cellulose gel, stearic acid, silica, hydroxypropylcel-
lulose, magnesium stearate and polyethylene glycol, but no
specific antoxidants.
As part of an on-going study related to the National Cancer
Institute human intervention trials previously reported19 and
proposed for the future,22 samples of selenium-enriched tablets
Fig. 1 Se-specific HPLC-ICP-MS chromatograms of the enzymatic
hydrolysis of 1250 ppm Se yeast (reference) using 0.1% HFBA ion
pairing agent, Symmetry Shield2 column (lower—Se-82 counts s21
response scale expanded).
used in the former trial were obtained from archived samples.
Representative tablets were crushed, after first manually
removing titanium dioxide coatings if present, and treated
enzymatically according to the standard protocol. Tablets were
chosen from various time periods of the trial from 1986–1993
and are designated N2, N5, N8 and N13. A more comprehen-
sive survey of the results from this study will be published
elsewhere. A representative HPLC-ICP-MS chromatogram is
shown in Fig. 2 for sample N5, showing a striking difference
from the selenized yeasts analyzed previously. While seleno-
methionine is still present, it occurs in a much lower proportion
and ‘unknowns’ U1 and U2 now appear as the predominant
components. In all archived tablets examined these three peaks
predominate in various proportions. Table 3 shows represen-
tative quantifiation of four archived tablets. Each result is for
replicate analyses for representative samples from 10 pooled
tablets of each batch. Repeatability was as noted above for
yeast samples.
Since all of the archived tablets showed substantially
different selenium profiles from the reference selenized yeast,
it appears that changes in speciation (as determined following
enzymatic treatment and extraction) have occurred, either from
lengthy storage, perhaps by oxidation, by interaction with
tablet excipients or perhaps by linked processes. An important
observation suggests that excipients in tablets are not involved
since a selenized yeast powder obtained from the University of
Arizona archives designated as ‘Clark yeast’, which was used in
the preparation of ‘N’ series samples, gave a profile very similar
to that of N5 (Fig. 2). Fig. 2 also compares these profiles with
that of reference yeast powder employed to prepare currently
manufactured selenized yeast tablets (SelenoExcell2).
Oxidation of selenoamino acids
The selenoxides of selenoamino acids have been found in
natural samples26–29 and, in the case of selenized yeasts or
nutritional supplement extracts, selenium compounds eluting
early under reversed phase mobile phase conditions, may be
such oxidation products.
Amino acid selenoxides have been synthetically produced
and studied, primarily because of interest in the antioxidant
activity of selenium. Gammelgaard et al. recently carried out an
exhaustive study of the oxidative degradation of selenomethio-
nine.30 These workers separated oxidation products during the
course of the process and used ICP-MS, LC-MS and NMR to
identify major compounds. Selenomethionine selenoxide and
methaneseleninic acid were fully characterized.
We have previously reported the examination of oxidation of
selenoamino acids by HPLC-ICP-MS and found differing
products for different acids.11,12 In particular, small pH
changes in HPLC separation conditions may give rise to
Table 2 Selenium compounds determined in enzymatic extracts of yeast samples with different total selenium content
Se-species
(Table 1)
1250 ppm
yeast
1204 ppm
yeast
1258 ppm
yeast
1406 ppm
yeast
1500 ppm
yeast
550 ppm
yeast
1200 ppm
yeast
1220 ppm
yeast
1150 ppm
yeast
1 0.09% 0.2% 0.4% 0.4% 0.04% 0.03% 0.1% 0.09$ 0.5%
12 84%a 77.2% 62.5% 77.4% 83.3% 89.1% 66.5% 74.5% 74%a
15 0.54% 0.9% 1.6% 1.2% 0.9% 0.1% 0.9% 0.9% —
18 0.5%a 0.9% 4.7% 7.4% 5% 4.8% 5.9% 4.4% —
SUM 85.1% 79.2% 69.2% 86.3% 89.2% 94% 73.4% 79.9% 74.5%
a %Se distributions are expressed in terms of total selenium content eluting from the column. Compounds with distribution percentage values
marked with an asterisk were confirmed by HPLC-ESI-MS.
Fig. 2 HPLC-ICP-MS chromatograms of the enzymatic hydrolysis
of (a) SelenoExcell2 yeast, (b) Clark yeast and (c) Clark yeast tablet
(N5), using 0.1% HFBA as ion-pairing agent. XTerra2 column
Table 3 Selenium distribution (%) in the archived selenized yeast tablet extracts
1 2 12 15 18 U-1 U-2 Sum
N2 — 9.5 8.4 — — 58.3 17.3 93.5
N5 — 2.9 24.6 1.3 3.1 52.8 10.9 95.6
N8 — 3.3 19.5 — 2.4 38.9 21.6 85.7
N13 — 11 7.4 — 2.2 54.3 15.5 90.4
a 1 ~ Selenate, 2 ~ selenite, 12 ~ selenomethionine, 15 ~ c-glutamyl-Se-methylselenocysteine, 18 ~ Se-adenosylselenohomocysteine, U-1 ~
unknown 1, U-2 ~ unknown 2. Designations N2, N5, N8 and N13 are representative of sequentially numbered supplements administered in
the ‘Clark study’, 1983–1993.22
data needing careful interpretation, especially as regards reten-
tion time shifts. Thus, while the primary product of peroxide
oxidation of selenomethionine is selenomethionine selenoxide
hydrate, oxidation of Se-methylselenocysteine generates metha-
neseleninic acid among other products.11,26 The treatment of
SelenoExcell2 yeast with excess hydrogen peroxide was now
investigated, and the major product identified as selenomethio-
nine selenoxide hydrate elutes at ca. 2.5 min on the Symmetry
Shield2 column. In addition, a small amount of selenite is
present after the oxidation.
In the enzymatic extraction of SelenoExcell2 yeast two
major components were found: selenomethionine and ‘‘U1’’ at
ca. 2.5 min on the Symmetry Shield2 column (Fig. 1). Since
‘‘U1’’ elutes in the early part of the chromatogram it is
considered to be hydrated selenomethionine selenoxide. This is
minimally retained due to the enhanced polarity imparted by
the addition of oxygen and the elements of water to the
selenium atom, producing greater affinity for the acidic
aqueous mobile phase. The formation of the hydrate under
such acid conditions has been reported elsewhere.30,31 The mass
spectrum of oxidized selenomethionine was confirmed as
reported by Bird to indicate the presence of hydrated
selenomethionine selenoxide with a selenium ion cluster (Se-
80 molecular ion at m/z 232).32 Larsen et al. have described an
ion exchange HPLC-ICP-MS study in which selenomethionine
selenoxide was observed and confirmed.14 ‘U2’ is chromato-
graphically retained similarly to selenomethionine and thus is
considered to have a considerably less polar structure than the
hydrate. Its retention is in the region typically seen for ion
paired selenamino acids.
Reduction of oxidized SelenoExcell2
As was noted earlier,16 the oxidation of selenomethionine to
selenomethionine selenoxide is reversible upon reduction by
thiosulfate in aqueous solution, as shown by proton NMR.33
For selenomethionine standards, we confirmed earlier by
HPLC-ICP-MS that quantitative recovery of non-oxidised
selenomethionine occurs upon treating the hydrated seleno-
methionine selenoxide with excess thiosulfate.16
Upon addition of thiosulfate to oxidized SelenoExcell2
yeast extract, the peak considered to be selenomethionine
selenoxide hydrate reverted to selenomethionine, the chroma-
tographic profile of which was, however, complicated by
broadening and double peaking, the extent of which was
dependent on the amount of thiosulfate added with resulting
pH change. Such behavior was attributed to equilibrium
between non-protonated and protonated/ion paired forms of
selenomethionine.13 Coincidentally this chromatographic peak
behavior overlapped with U2 and led initially to an erroneous
conjecture that U2 corresponded to another ‘derivative’ of
selenomethionine, perhaps the nonhydrated selenomethionine
selenoxide. This supposition was, however, considered unlikely
since at the pH of the HFBA mobile phase of 2.55, only the
hydrated form would be expected.13 This behavior prevented
the archived samples from being usefully subjected to the
oxidation–reduction sequence as U2 was masked by the
behavior of selenomethionine. The need for an alternative
independent analytical procedure to elucidate U2 was clear.
Gas chromatography
Capillary gas chromatography provides sensitive, high-resolu-
tion analysis for analytes of sufficient volatility, or following
chemical derivatization to convert non-volatile species to
volatile ones. When coupled with atomic emission detection
(AED), selenium in target molecules is directly monitored by
spectroscopic detection of atomic emission radiation at a
wavelength characteristic of the element, providing both
qualitative elemental speciation and quantitation.34,35 We
have used GC-AED to detect and determine many volatile
organoselenium compounds present in or produced by plants
such as garlic, elephant garlic, onion and broccoli.21 A common
structure is R–Sx(Sey)–R’, where R and R’ are methyl or allyl
groups.
Derivatization with alkyl chloroformates provides an effective
route to volatile species for amino acid GC. Selenoamino acids
have been derivatized for GC with isopropyl chloroformate,36
and ethyl chloroformate; selenocysteine, Se-methylselenocys-
teine and selenomethionine have been determined in normal
and selenium-enriched plants using GC-AED.37,38
Depicted in Fig. 3 is a GC-AED chromatogram (Se at
196 nm) of the ethyl chloroformate derivatives of six
selenoamino acids, all of which elute within a seven minute
window with excellent resolution and peak efficiencies. The
retention times of these species are shown in Table 4. The
longer retention time of the selenocysteine derivative results
from the fact that derivatization takes place at the Se–H group
as well as the amino and carboxylate functions.
Fig. 4 shows the GC-AED (Se at 196 nm) of derivatized
Clark yeast and SelenoExcell2 yeast extract prepared by the
Protease XIV digestion of yeast powders, and of derivatized
selenomethionine as a reference. These were the same samples
as investigated by HPLC-ICP-MS as described earlier. It is
apparent (Fig. 4) that the Clark yeast chromatogram contains
more peaks than the SelenoExcell2 or selenomethionine
chromatograms. Particularly interesting is the peak appearing
at ca. 35 min in the region corresponding to derivatized seleno-
amino acids. In Fig. 5 a comparison of selenium chromato-
grams for archived N2, N5 and N8 archived tablets prepared
Fig. 3 GC-AED temperature programmed chromatogram of deriva-
tized selenoaminoacids. (1)Se-methylselenocysteine, (2) selenomethionine,
(3) Se-allylselenocysteine, (4) Se-propylselenocysteine, (5) selenoethionine
and (6) selenocysteine.
Table 4 Standard derivatized selenium compounds in a standard
solution with their molecular weights (for Se 80) and retention times
Name
Molecular
weight
Retention
time/min
Se-Methylselenocysteine derivative 283 30.75
Selenomethionine derivative 297 33.52
Se-Allylselenocysteine derivative 309 33.95
Se-Propylselenocysteine derivative 311 34.20
Selenoethionine derivative 311 35.00
Selenocysteine derivative 341 36.75
by Protease XIV digestion followed by derivatization are seen.
The selenium-containing component at 35 min appears for
each of the tablets to varying degrees.
A key advantage of GC-AED is the facility to display
simultaneously a number of element specific chromatograms
for different elements. In this fashion, carbon, sulfur and
selenium chromatograms can be displayed simultaneously.
Fig. 6 shows comparative C, S and Se chromatograms for the
Clark yeast. The selenium and sulfur traces indicate the
presence of both of these elements in the peak eluting at ca.
35 min. Independent calibrations performed to estimate
relative responses of S and Se under the set plasma conditions,
using derivatized methionine and selenomethionine as stan-
dards,39 showed the selenium response at 196 nm to be
approximately four times the sulfur response at 181 nm.
Accordingly it was concluded from Fig. 6 that the species
contained equal numbers of Se and S atoms. Further, given the
retention time of the peak, only one of each atom could be
present in the parent molecule, presumed to be a selenoamino
acid. Additional strong evidence for the existence of both S and
Se in the molecule was gained from spectral examination of the
plasma emission present at this peak, the sulfur emission lines
at 181, 182 and 183 nm being seen as well as the selenium
196 nm emission line.
Other evidence was gathered to shed light on the possible
nature of this 35 min peak, which was conjectured at this stage
to be produced by derivatization of the peak denoted U2 in the
liquid chromatograms. Thus, treatment of the Clark yeast
extract with 50 mM dithiothreitol, a reagent established to
cleave S–S or Se–Se bonds, removed the 35 min peak from the
GC-AED chromatogram while leaving the derivatized seleno-
methionine peak untouched. A similar experiment performed
using HPLC-ICP-MS analysis gave the same result. Addition-
ally the U2 peak was carefully trapped from the HPLC column
for a number of injections and concentrated by freeze-drying.
After derivatization this fraction also showed the 35 min peak
in S and Se channels by GC-AED (Fig. 7).
Evidence was now growing that U2 was an amino acid
containing a Se–S bond. Such was the low level of the species
present and the preponderance of other co-eluting non-
selenium species in the HPLC present in the proteolytically
extracted yeast that direct HPLC-mass spectrometry proved to
be impossible with the available instrumentation. Accordingly,
the ethylated derivative was examined by gas chromatography-
mass spectrometry.
Fig. 8 shows the total ion chromatogram of the derivatized
extract and the mass spectrum obtained at the peak eluted at a
Fig. 4 GC-AED (Se 196 nm) of derivatized selenomethionine, Clark
yeast and SelenoExcell2 yeast. Baseline offset for display purposes:
Reference yeast trace, baseline is at 112 000 counts; Clark yeast trace,
baseline is at 125 000 counts.
Fig. 5 GC-(Se 196 nm) of N2, N5 and N8 Clark yeast tablets using
the enzymatic extraction method and derivatization by ethyl chloro-
formate. Baseline offset for display purposes: N2 trace, baseline is at
1300 counts; N5 trace, baseline is at1400 counts, N8 trace, baseline is
at 1500 counts.
Fig. 7 GC-AED (Se 196 nm and S 181 nm) of trapped fraction
collected fromHPLC ofUnknown 2, derivatized by ethyl chloroformate.
Fig. 6 GC-AED chromatogram of derivatized Clark yeast using the
enzymatic extraction and treatment with ethyl chloroformate.
retention time corresponding to the 35 min peak in GC-
AED. The main features of the spectrum were readily
interpreted as follows. The molecular ion peak (M1) is seen
at m/z 315 (80Se) and it also showed the selenium isotope
pattern. The cluster of ions at m/z 242 suggests the selenium
isotope pattern and loss of COOCH2CH3 (m/z 73) from the
molecular ion (M1). The prominent ion at m/z 220 indicates the
loss of SeCH3 (m/z 95) and shows no selenium isotope pattern.
The ion at m/z 188 may be interpreted as the loss of SSeCH3
(m/z 127) and that at m/z 174 as due to the loss of CH2SSeCH3
(m/z 141). This spectrum gives a strong indication that the U2
molecule contained the CH2SSeCH3 moiety and was also an
amino acid. The conjectured acid is thus S-(selenomethyl)-
cysteine, CH3SeSCH2CH(NH2)COOH, a previously unre-
ported species.
While it was considered that there was good evidence for this
assignment, the independent synthesis of this molecule was
accomplished and will be reported elsewhere.40 This synthetic
sample was derivatized by the standard method and showed the
GC-MS characteristics in Fig. 9. In this spectrum, the principal
features are much simpler to observe since the ion background
is much lower. The principal ions at m/z 315, 242, 220, 188 and
174 appear clearly. There are possible assignments based upon
apparent selenium isotope patterns of fragments CH2SSeCH3
(m/z 141) and SeCH3 (m/z 95). There is a direct correspondence
with the U2 derivative and it is considered that the evidence of
identification is conclusive.
Conclusion
High-seleniumyeast inbothfreeyeastandtabletedforms, storedat
room temperature for more than ten years, gives rise, after
subjection to proteolytic digestion and extraction, to substantial
amounts of selenomethionine selenoxide hydrate and the pre-
viously unreported selenoamino acid S-(selenomethyl)cysteine.
These observations have important nutritional and perhaps
Fig. 8 (a) GC-MS total ion chromatogram of Clark yeast using the extraction method and derivatized by ethyl chloroformate; (b) mass spectrum
of the unknown peak U2 in Clark yeast, molecular ion m/z ~ 315 (80Se).
metabolic implications. The species now identified as seleno-
methionine selenoxide hydrate is also observed in smaller
proportions for some contemporary selenized yeasts and it is
reasonable to conclude that oxidation of selenomethionine in
the presence of water contributes variously to this finding in
different samples. From the standpoint of nutritional efficacy
and selenium uptake, it is possible that the selenoxide is
equivalent in action to selenomethionine and is metabolized in
the same way. The inclusion of the selenoxide in quantitative
measurement of selenomethionine content for selenized yeast
seems reasonable. The existence of S-(selenomethyl)cysteine
has broader import that will be examined further. Perhaps the
presence of this Se–S species may be related to as yet undefined
selenium metabolism. It is not known if speciation changes can
occur over the shorter time that the product might be held in
storage, but closer examination of other current yeast products
suggests that a previously unidentified component present at
low concentrations may be S-(selenomethyl)cysteine. Studies
using the Se-fingerprint method to evaluate the effects of
accelerated aging (i.e., high-temperature exposure) on the
pattern of Se-compounds in selenized yeast are clearly
important. Combs et al.41 recently reported the direct
measurement of the hitherto unrecognized fraction of plasma
containing low molecular weight (v5 kD) Se compounds. This
is an important finding; inasmuch as it indicates the presence in
plasma of one or more Se-species that, if they can be
characterized, may offer new and more informative ways to
assess Se metabolic status.
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